➡️ The anti-L1CAM antibody ABCD_AN179, a recombinant alternative to the CE7 hybridoma derived monoclonal antibody, has been validated for flow cytometry on rhabdomyosarcoma cell lines.
🙌 Congratulation and thank you Michele Bernasconi and Caroline Piccand for taking the time to publish this antibody validation data in AntibodyReports. It will be useful for the entire scientific community!
https://oap.unige.ch/journals/abrep/article/view/2341
